Human lung tissue transcriptome : Influence of sex and age by M. Dugo et al.
RESEARCH ARTICLE
Human Lung Tissue Transcriptome: Influence
of Sex and Age
Matteo Dugo1‡, Chiara E. Cotroneo2¤‡, Emilie Lavoie-Charland3, Matteo Incarbone4,
Luigi Santambrogio5, Lorenzo Rosso5, Maarten van den Berge6, David Nickle7, Peter
D. Pare´8,9, Yohan Bosse´3,10, Tommaso A. Dragani2*, Francesca Colombo2
1 Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei
Tumori, Milan, Italy, 2 Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto
Nazionale dei Tumori, Milan, Italy, 3 Institut Universitaire de cardiologie et de pneumologie de Que´bec,
Que´bec, Canada, 4 Department of Surgery, San Giuseppe Hospital–MultiMedica, Milan, Italy, 5 Fondazione
IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy, 6 University of Groningen, University
Medical Center Groningen, Department of Pulmonology, Groningen Research Institute for Asthma and COPD
(GRIAC), Groningen, The Netherlands, 7 Merck & Co. Inc., Rahway, NJ, United States of America,
8 University of British Columbia Center for Heart Lung Innovation and Institute for Heart and Lung Health,
St. Paul’s Hospital, Vancouver, BC, Canada, 9 Respiratory Division, Department of Medicine, The University
of British Columbia, Vancouver, BC, Canada, 10 Department of Molecular Medicine, Laval University,
Que´bec, Canada
¤ Current address: UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield,
Dublin, Ireland.
‡ These authors are co-first authors on this work.
* tommaso.dragani@istitutotumori.mi.it
Abstract
Background
Sex and age strongly influence the pathophysiology of human lungs, but scarce information
is available about their effects on pulmonary gene expression.
Methods
We followed a discovery-validation strategy to identify sex- and age-related transcriptional
differences in lung.
Results
We identified transcriptional profiles significantly associated with sex (215 genes; FDR <
0.05) and age at surgery (217 genes) in non-involved lung tissue resected from 284 lung
adenocarcinoma patients. When these profiles were tested in three independent series of
non-tumor lung tissue from an additional 1,111 patients, we validated the association with
sex and age for 25 and 22 genes, respectively. Among the 17 sex-biased genes mapping on
chromosome X, 16 have been reported to escape X-chromosome inactivation in other tis-
sues or cells, suggesting that this mechanism influences lung transcription too. Our 22 age-
related genes partially overlap with genes modulated by age in other tissues, suggesting
that the aging process has similar consequences on gene expression in different organs.
Finally, seven genes whose expression was modulated by sex in non-tumor lung tissue,
but no age-related gene, were also validated using publicly available data from 990 lung
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Conclusions
Gene expression in non-tumor lung tissue is modulated by both sex and age. These findings
represent a validated starting point for research on the molecular mechanisms underlying
the observed differences in the course of lung diseases among men and women of different
ages.
Introduction
In humans, males and females share a common genome, except for a relatively small number
of genes on the Y chromosome; however, the two sexes are noticeably different in morphology,
physiology, and behavior. Whole genome analysis of gene expression in different tissues has
shown widespread sex differences in the transcriptional profiles of genes [1–3]. This phenome-
non, called sex-biased gene expression, has been attributed to the existence of pleiotropic
effects of sex on the regulation of gene expression [1–3]. A study in Drosophila has indeed
shown that female-biased genes on chromosome X have pleiotropic effects [4].
In addition to sex, other biological factors that strongly influence gene expression are age
and the process of aging. Indeed, in studies that used genome-wide analyses, age-related
changes in transcriptome profiles have been observed in several human tissues, including kid-
ney, muscle, brain, skin, blood and adipose tissue [5–8]. However, there is still open debate on
whether the aging process causes similar transcriptional changes in all tissues, and, therefore,
if it is possible to identify a common aging signature, or if it predominantly induces tissue-spe-
cific molecular changes. Indeed, one study found that only a few genes are commonly affected
by age in skin, adipose and brain [6], whereas another found six common age-modulated path-
ways in a comparison of muscle, kidney and brain [7]. Finally, a meta-analysis of multiple tis-
sues from humans, rats and mice identified common signatures of aging involving, for
example, immune/inflammatory responses, cell growth, energy metabolism, and extracellular
matrix components [8].
In lung, the effects of age and sex on gene expression are just beginning to be investigated.
One study of post-mortem lung tissue from multiorgan donors found 40 genes that were dif-
ferentially expressed between 7 young and 6 old persons and obtained preliminary results
about sex-related differences in gene expression [9]. Substantially more information is avail-
able about the effects of age and sex on lung function and cellular physiology. In general, pul-
monary function declines with age, even in the absence of respiratory disease. The elderly
population has decreased lung volumes, less efficient functionality of respiratory muscles and
reduced forced expiratory volumes, accompanied by modifications in innate and adaptive
immunity (reviewed in [10]). Lung anatomy and physiology as well as the etiology of some
respiratory diseases (e.g. asthma, allergic rhinitis, pulmonary hypertension, cystic fibrosis)
have been reported to show sex differences, from prenatal lung development to adulthood;
some studies suggested a possible role of sex hormones to explain these differences, but socio-
cultural and genetic differences between the sexes are also thought to be involved (reviewed in
[11]).
In lung cancer, there are conflicting data on the effects of age and sex. Two large cohort
studies reported better survival in women than men [12,13]. Age at diagnosis did not associate
with survival in surgically treated patients with stage I non-small cell lung cancer [14]. We
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previously observed that neither age at diagnosis nor sex was significantly associated with sur-
vival in patients with lung adenocarcinoma [15]. In light of this uncertainty, and considering
the relevance of age and sex on lung function in health and disease, greater knowledge about
the genes modulated by these biological parameters in lung tissue is needed. Such information
is crucial for understanding the molecular mechanisms underlying the observed physiological
differences among individuals in the absence of disease, and may also help uncover new targets
for the treatment of lung pathologies.
In the present work, we studied the role of sex and age on gene expression in lung tissue, by
doing a statistical reanalysis of existing microarray data. We first identified genes affected by
sex and age in samples of non-involved lung tissue resected from men and women with lung
adenocarcinoma over a broad range of ages (discovery series, [15]). We then determined
which of these genes were also differentially expressed in three other series of non-tumor lung
tissue (validation series, [16]). Finally, we examined public datasets of gene expression in lung
tumors to determine if the sex- and age-biased transcriptomic profiles observed in non-tumor
lung tissue are also detectable in lung cancer tissue.
Materials and Methods
Ethics statement
The present study used existing microarray data from four independent clinical series, already
described [15,16]. Those papers detailed the approval of the study protocols by the institutional
ethics committees (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Istituto
Clinico Humanitas, Rozzano, Italy, Ospedale San Giuseppe, Milan, Italy, Fondazione IRCCS
Cà Granda Ospedale Maggiore Policlinico, Milan, Italy, Institut Universitaire de cardiologie et
de pneumologie de Que´bec, Que´bec, Canada, University of British Columbia, Vancouver, BC,
Canada, University of Groningen, Groningen, The Netherlands) and the collection of surgical
samples and clinical data from patients who had provided broad informed consent allowing
the materials to be used for research purposes; even though follow-up studies were not explic-
itly authorized, neither were they explicitly refused, and it was expected by all parties involved
that the samples and data would support multiple studies. At the recruitment, the authors got
the data that have been, then, used in this study. The current analysis did not require addi-
tional ethical approval, because it is a continuation of the originally approved studies on data
that were full available prior to their use in this study.
Discovery series
The discovery series consisted of 284 samples of non-involved (apparently normal) lung
parenchyma (sampled as far as possible from tumor tissue), and the associated clinical data,
from patients who had had lobectomy for lung adenocarcinoma at the Fondazione IRCCS Isti-
tuto Nazionale dei Tumori and at other hospitals in the area of Milan, Italy. Details about sam-
ple collection, RNA extraction and gene expression profiling on Illumina HumanHT-12 v4
Expression BeadChips have already been reported [15]. Because that study also had a discov-
ery-validation design, the microarray analysis had been done on consecutive sets of 206 and 78
samples (although 2 samples from the first set had been excluded from analysis due to the lack
of follow-up data).
The analysis of raw microarray data was done at Fondazione IRCCS Istituto Nazionale dei
Tumori in Milan essentially as previously described [15]. Briefly, the two datasets of 206 and
78 samples were processed independently using log2 transformation and robust spline normal-
ization, implemented in the lumi package [17] of the open source software Bioconductor [18].
Then, the two sets were combined using the ComBat adjustment method [19] implemented in
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the sva R package [20]. Probes that were not annotated and those with a detection P
value < 0.01 in fewer than 10% of samples were filtered out. Finally, when multiple probes
mapped to the same transcript, we included only the one with the highest detection rate,
defined as the percentage of samples in which the probe had detection P values < 0.01. Gene
expression data were deposited in the Gene Expression Omnibus database (GEO, http://www.
ncbi.nlm.nih.gov/geo/) with accession number GSE71181.
Validation series
This study also used three validation series, consisting of the discovery and replication sets of
another previous work [16]. Here, those sets are called the Laval (n = 409), University of Brit-
ish-Columbia (UBC; n = 339) and Groningen (n = 363) series according to the names of the
sites were the patients had lung resection surgery, namely Laval University (Quebec, Canada),
University of British-Columbia (Vancouver, Canada), and University of Groningen (Gro-
ningen, The Netherlands), respectively. In all cases, non-tumor lung tissues were sampled.
The previous publications [16,21] detailed the sample collection, RNA extraction and gene
expression profiling on custom Affymetrix arrays for all three series. Briefly, expression values
were extracted from microarray data using the robust multichip average (RMA) method [22].
When two or more probe sets mapped to the same transcript, the one with the greatest number
of present calls was selected. The resulting microarray data were deposited in the GEO data-
base with accession number GSE23546.
Datasets on gene expression in lung cancer
To further validate our findings we downloaded, from the GEO database, five public datasets
(GSE68896, GSE30219, GSE31210, GSE37745, and GSE41271). GSE68896 contains normal-
ized gene expression data from fetal lung tissue, whereas GSE30219, GSE31210, GSE37745,
and GSE41271 contain normalized gene expression data from patients with lung cancer for
whom data about age at surgery and sex were available (S1 Table). From each lung cancer
dataset, we discarded the records about normal lung tissue samples.
Statistical analysis
Associations of gene expression data with sex and age at surgery (used as dichotomous and
continuous variables, respectively) were tested using linear regression modeling. Smoking
habit was used as a covariate in the validation series but not in the discovery series, as all sam-
ples except one were from smokers, nor in the public lung cancer tissue datasets which lacked
information about smoking status.
In the validation phase, the two sets of sex- and age-associated genes were tested indepen-
dently in each validation series. In both discovery and validation phase, all P-values were cor-
rected for multiple testing using the Benjamini-Hochberg false discovery rate (FDR) method
[23]; the threshold for statistical significance was set at FDR< 0.05.
To identify sex- and age-biased known biological pathways, we ran gene set enrichment
analysis (GSEA) using GSEA v2.0.13 software [24]. Results were visualized using Cytoscape
v2.8.3 software [25] and the Enrichment Map plugin [26].
Results
To study the effects of sex and age on gene expression in lung tissue, we analyzed a discovery
series of 284 surgical samples from Italy [15] and three validation series from Canada and the
Netherlands [16] (Table 1). The discovery series had a predominance of men (71.1%) and all
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but one were ever-smokers. The validation series had a more balanced sex distribution, with
men representing 53%–56%, and included patients who were never-smokers as well as current
and former smokers. In the discovery series, age of both male (Fig 1A, left) and female (Fig
1A, right) patients showed a wide distribution, ranging from 36 to 85 years in males
(median = 67 years) and from 40 to 83 years in females (median = 62 years). Age also showed
a wide distribution in the three validation sets. For Laval, age ranged from 30 to 82 years in
males (Fig 1B, left, median = 66 years) and from 33 to 84 years in females (Fig 1B, right,
median = 62 years). For UBC, age ranged from 11 to 85 years in males (Fig 1C, left, median = 64
years) and from 4 to 82 years in females (Fig 1C, right, median = 61 years). For Groningen,
age ranged from 6 to 83 years in males (Fig 1D, left, median = 56 years) and from 8 to 75 years
in females (Fig 1D, right, median = 53 years).
All patients in the discovery series had been treated for lung adenocarcinoma, while the val-
idation series included patients with a variety of different lung cancer types and even patients
who had other lung diseases. In all cancer cases, the surgical samples were apparently normal,
having been taken from the non-diseased margins of the resected tissue. Considering the rea-
sons for which the patients had lung resection, their smoking habits and their ages at surgery,
the Laval validation series was the most similar to the discovery series.
Discovery of transcripts in lung tissue that associate with sex and age
Expression data were available regarding 11,089 genes for the discovery series [15]. Of these,
215 genes (2%) were differentially expressed between men and women (S2 Table). In
Table 1. Clinical characteristics of patients from whom a sample of resected non-tumor lung tissue was included in the discovery and validation
series.
Discovery Series (n = 284) Validation series
Laval (n = 409) UBC (n = 339) Groningen (n = 363)
Gender
Men 202 (71.1) 229 (56.0) 182 (53.7) 193 (53.2)
Women 82 (28.9) 180 (44.0) 157 (46.3) 170 (46.8)
Age at surgery, years, mean (SD) 64.7 (9.2) 63.3 (9.9) 60.2 (14.3) 51.5 (15.5)
Smoking status
Current smoker 283 (99.7)a 90 (22.0) 98 (28.9) 57 (15.7)
Former smoker -a 283 (69.2) 163 (48.1) 185 (51.0)
Never-smoker 1 (0.3) 36 (8.8) 26 (7.7) 100 (27.5)
Unknown 0 (0) 0 (0) 52 (15.3) 21 (5.8)
Reason for surgery
Lung cancer 284 (100) 408 (99.8) 274 (80.8) 123 (33.9)
Other 0 (0) 1 (0.2) b 65 (19.2) b 240 (66.1) b
Lung cancer histotype
Adenocarcinoma 284 (100) 235 (57.6) 88 (32.1) 37 (30.1)
Squamous cell carcinoma 0 (0) 104 (25.5) 86 (31.4) 54 (43.9)
Carcinoid 0 (0) 17 (4.2) 15 (5.5) 2 (1.6)
Small cell lung carcinoma 0 (0) 7 (1.7) 23 (8.4) 2 (1.6)
Other 0 (0) 45 (11.0) 62 (22.6) 28 (22.8)
Values are n (%) unless indicated otherwise.
a In the discovery series, individuals are categorized as either never-smokers or ever-smokers, without distinguishing the latter into current smokers or ex-
smokers.
b Patients underwent therapeutic lung resection for lung transplantation or for small peripheral lung lesions.
doi:10.1371/journal.pone.0167460.t001
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particular, 122 genes were up-regulated and 93 genes were down-regulated in men compared
to women (FDR< 0.05). All genes had a fold change between -2 and 2 except for two: RPS4Y1,
mapping on chromosome Y, was 48-fold up-regulated in men (compared to the background
probe intensity measured in females, who do not carry the gene), while XIST, mapping on
chromosome X, was 12-fold down-regulated. Altogether, 30 sex-associated genes mapped to
the non-pseudoautosomal region of chromosome X, one mapped to the non-pseudoautosomal
region of chromosome Y, four mapped to the pseudoautosomal regions, and the remaining
180 genes mapped to autosomes. To determine if these genes distinguishing the normal lung
tissue of male and female individuals were associated with particular biological pathways or
functions, we performed gene set enrichment analysis (GSEA) [24] using gene sets from the
Gene Ontology collection (C5.all.v4.0, retrieved from http://www.broadinstitute.org/gsea/
msigdb/index.jsp). Despite the large number of genes affected by sex, no gene set was found to
be enriched in male vs. female individuals.
We then examined the effect of age at surgery on gene expression and found 217 genes that
were significantly associated with patients’ age (FDR< 0.05; S3 Table). In particular, the expres-
sion of 124 genes was positively associated with age, while 93 genes showed a decreased expression
in older patients. GSEA revealed that two major functional themes displayed an altered expression
in older patients (Fig 2). The first included gene sets related to extracellular matrix components
and functions, with genes encoding, for example, collagens, laminins and metallo-proteinases.
The second comprised gene sets related to pro-inflammatory responses and wound healing.
In order to evaluate a possible effect of chance in finding a number of sex- or age-associated
genes similar to those observed in this study, we performed a permutation analysis on the dis-
covery series by randomly assigning sex and age labels for 1,000 times; at each permutation
cycle, we calculated: i) the total number of genes with FDR < 0.05, to determine the expected
number of significant genes occurring by chance; ii) the number of times each of the 215 sex-
related and 217 age-related genes had an FDR< 0.05. We found that in 969 out of 1,000 per-
mutations no genes were significantly associated with sex, with an expected number of genes
by chance of 0.721. Results were similar for age, with 972 of 1,000 times with no significant
genes and with an expected number of genes by chance of 1.817. This analysis clearly indicates
that the limited number of genes that came out of the analysis was not casually generated.
Validation of the sex-biased transcriptional profile
We then attempted to validate the results from the discovery series in three independent vali-
dation series (Laval, n = 409; UBC, n = 339; and Groningen, n = 363) [16]. Of the 215 genes
associated with sex in the discovery phase, six were not represented on the platform used to
profile the validation datasets. For the remaining 209 genes, the possibility of false-positive
results due to the high number of statistical tests carried out was taken into account by correct-
ing the obtained P-values for multiple testing with the Benjamini–Hochberg procedure and
setting a significance threshold of FDR< 0.05. With this analysis, 94 genes in the Laval series
showed statistically significant and concordant associations with sex and were therefore vali-
dated. In addition, 55 genes in the UBC series and 33 in the Groningen series were also vali-
dated. Intersection of the lists of genes significantly associated with sex in each of the four
datasets (discovery, Laval, UBC and Groningen) highlighted a common set of 25 genes that
were validated in all series (Fig 3).
Fig 1. Age distributions of discovery and validation series. Histogram of age at surgery of male (left
panels) and female (right panels) lung cancer patients of the discovery (A) and validation series (B: Laval
University; C: University of British Columbia; D: University of Groningen).
doi:10.1371/journal.pone.0167460.g001
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This common set of sex-biased genes in non-tumor lung tissue included five genes that
were up-regulated and 20 that were down-regulated in men compared to women. Overall, five
of the genes mapped to four different autosomes, 17 mapped to the X chromosome and one to
the Y chromosome (pseudo-autosomal regions excluded), and two mapped to the pseudoauto-
somal regions (Table 2). The two genes that showed an absolute fold change greater than 2
between males and females in the discovery series (RPS4Y1 and XIST) were included in this
set.
To assess whether transcriptional differences in the lung of males and females arise at early
stages of development, we analyzed public gene expression data of fetal lung tissues
(GSE68896, downloaded from the Gene Expression Omnibus database at http://www.ncbi.
nlm.nih.gov/geo/). Interestingly, we found that 18 of the 25 validated sex-related genes identi-
fied in adult lung tissue (Table 2) were also differentially expressed between male and female
fetal lung tissues (S4 Table).
Fig 2. Two major functional themes displayed an altered expression in older patients. Network-based visualization of gene
sets enriched in lung tissue in association with age, in 284 patients who underwent lobectomy for lung adenocarcinoma; the
analyzed lung tissue was not involved by cancer. Gene set enrichment analysis (GSEA) was carried out using GSEA v2.0.13
software [24]. Briefly, we first ranked genes of the discovery dataset according to the t-statistic of age and sex. Then, gene sets
derived from the Gene Ontology database (C5.all.v4.0) were retrieved from the Molecular Signature Database (MSigDB, http://www.
broadinstitute.org/gsea/msigdb/index.jsp) and tested for enrichment using a Kolmogorov-Smirnov statistic. Only the 653 gene sets
having between 15 and 500 genes were tested for enrichment. An FDR < 0.05 identified significantly enriched gene sets. GSEA
results were visualized using Cytoscape v2.8.3 software [25] and the Enrichment Map plugin [26], with an overlap coefficient cut-off
of 0.5. Circles (nodes) represent C5 Gene Ontology gene sets connected by lines (edges) whose thickness is proportional to the
number of genes shared between the connected nodes. Circle sizes are proportional to the number of genes annotated in each gene
set. Two independent clusters of functionally related gene sets were detected, one (on the left) involving extracellular matrix and the
other one (on the right) involving pro-inflammatory response and wound healing.
doi:10.1371/journal.pone.0167460.g002
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We also attempted to validate the results from the discovery series in four publicly available
datasets of gene expression in lung cancer samples (GSE30219, GSE31210, GSE37745, and
GSE41271). As these four datasets were profiled with different platforms, data were available
for 169 of the 215 genes associated with sex in the discovery series. Among these 169 genes, 52
showed a statistically significant (FDR< 0.05) and concordant association with sex in at least
one cancer dataset (not shown). The discovery series and the four tumor series shared a com-
mon set of seven sex-biased genes, namely ARSD, CD99,GEMIN8,OFD1, RPS4X, RPS4Y1, and
XIST. Interestingly, all of these genes also belonged to the common set of genes validated in all
three series of non-tumor lung tissue.
Fig 3. Intersection of the lists of genes significantly associated with sex in each of the four datasets. Four-
way Venn diagram analysis of sex-related transcriptional alterations in non-tumor lung tissue. Each of the circles
depicts the number of different transcripts based on a sex comparison for each of the labeled data series (yellow,
INT, Italian discovery series; green, Laval validation series; blue, Groningen validation series; red, UBC validation
series) among the 215 transcripts identified as statistically significant in the Italian discovery series. Shared
transcripts are represented in the areas of intersection between two or more circles. Genes whose expression
levels were positively and negatively associated with sex in the different series are called “contra-regulated”; these
genes were not included among the number of validated genes.
doi:10.1371/journal.pone.0167460.g003
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Validation of the age-biased transcriptional profile
Among the 217 genes associated with age at surgery in the discovery series, 13 had not been
investigated in the three validation series (Laval, UBC, Groningen). After correcting for multi-
ple testing, the association with age (with the same direction of effect) was confirmed for 149
genes in the Laval series, 97 genes in the UBC series, and 32 genes in the Groningen series
(FDR< 0.05). The intersection of these sets identified 22 common genes showing a concor-
dant direction of effect in all four series (Fig 4). These included 15 up-regulated and 7 down-
regulated genes in older individuals, which were found on 14 different autosomes (Table 3).
The same analysis was repeated for the four public datasets of lung cancer specimens
(GSE30219, GSE31210, GSE37745, and GSE41271). Of the 217 age-associated genes found in
the discovery series, 178 had also been investigated in the four tumor series. Statistical analysis
showed that only one gene (IRX3) maintained a significant (FDR< 0.05) and concordant asso-
ciation in at least one of the four cancer datasets (not shown), and none maintained the associ-
ation in all four datasets. Therefore, it was not possible to identify a common set of genes
regulated by age in lung tumor tissue.
Discussion
In our discovery series of 284 lung adenocarcinoma patients, we identified 215 and 217 genes
whose expression levels in non-involved lung tissue were significantly associated with sex and
Table 2. Genes whose expression in lung tissue associated with sex in the discovery series and in all three validation series.
Gene symbol Gene name Gene Entrez ID Chr. Fold change 1 FDR 1
AOX1 Aldehyde oxidase 1 316 2 1.397 2.81E-04
ARSD Arylsulfatase D 414 X -1.543 5.78E-50
ATP6V1B1 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 525 2 -1.352 3.30E-04
CD99 CD99 molecule 4267 X;Y 1.342 5.85E-22
CILP Cartilage intermediate layer protein, nucleotide pyrophosphohydrolase 8483 15 1.397 1.24E-02
DDX3X DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked 1654 X -1.215 2.29E-04
EIF1AX Eukaryotic translation initiation factor 1A, X-linked 1964 X -1.336 1.34E-16
EIF2S3 Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa 1968 X -1.231 1.39E-16
GEMIN8 Gem (nuclear organelle) associated protein 8 54960 X -1.134 1.20E-04
HDHD1 Haloacid dehalogenase-like hydrolase domain containing 1 8226 X -1.586 1.75E-50
KAL1 Kallmann syndrome 1 sequence 3730 X -1.982 1.75E-30
KDM6A Lysine (K)-specific demethylase 6A 7403 X -1.514 4.96E-39
OFD1 Oral-facial-digital syndrome 1 8481 X -1.179 5.06E-04
OLFML2A Olfactomedin-like 2A 169611 9 -1.287 6.86E-03
PHGDH Phosphoglycerate dehydrogenase 26227 1 -1.170 3.64E-02
PRKX Protein kinase, X-linked 5613 X -1.131 2.38E-03
RPS4X Ribosomal protein S4, X-linked 6191 X -1.369 1.83E-09
RPS4Y1 Ribosomal protein S4, Y-linked 1 6192 Y 48.948 1.76E-249
TRAPPC2 Trafficking protein particle complex 2 6399 X -1.171 1.72E-07
TXLNG Taxilin gamma 55787 X -1.184 7.33E-07
USP9X Ubiquitin specific peptidase 9, X-linked 8239 X -1.084 2.15E-02
XIST X inactive specific transcript (non-protein coding) 7503 X -12.561 1.14E-171
ZBED1 Zinc finger, BED-type containing 1 9189 X;Y 1.108 3.91E-05
ZFX Zinc finger protein, X-linked 7543 X -1.382 3.14E-21
ZRSR2 Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 8233 X -1.362 2.54E-16
1 Values are those observed in the discovery series; males versus females, values > 1 indicate higher levels in males.
doi:10.1371/journal.pone.0167460.t002
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age, respectively. GSEA analysis revealed that no specific molecular functions were over-repre-
sented among the genes altered in males vs. females, whereas genes whose expression was
altered in older patients belonged to two major functional categories, i.e. extracellular matrix
function and pro-inflammatory response/wound healing. We validated 25 out of 215 sex-
related genes and 22 out of 217 age-related genes in three independent series of non-tumor
lung tissue (from a total of 1,111 individuals). Additionally, we validated a common set of
seven sex-biased genes in four publicly available datasets of transcriptional profiles of lung
tumor tissue (990 total individuals); no common age-associated genes were identified in all
four lung cancer datasets, and only one gene was validated in at least one of the four tumor
series.
Fig 4. Intersection of the lists of genes significantly associated with age in each of the four datasets. Four-
way Venn diagram analysis of age-related transcriptional alterations in non-tumor lung tissue. As in Fig 3, each of
the circles depicts the number of different transcripts based on age comparison for each of the labeled data series
(yellow, INT, Italian discovery series; green, Laval validation series; blue, Groningen validation series; red, UBC
validation series) among the 217 transcripts identified as statistically significant in the Italian discovery series.
Shared transcripts are represented in the areas of intersection between two or more circles. Genes whose
expression levels were positively and negatively associated with age in the different series are called “contra-
regulated”; these genes were not included among the number of validated genes.
doi:10.1371/journal.pone.0167460.g004
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Regarding the effect of sex on lung tissue transcription, we observed that 17 of the 25 sex-
biased genes map to the non-pseudoautosomal region of chromosome X and displayed higher
expression in females. These genes have probably escaped X-chromosome inactivation, i.e. the
mechanism by which mammals balance gene expression between the sexes through the silenc-
ing of one X chromosome in somatic cells of females [27]. Indeed, all these genes have been
observed to escape X-chromosome inactivation in an in vitro assay using rodent/human
somatic cell hybrids [28], with the exception of ZRSR2which was not tested in that study. X-
chromosome inactivation is regulated by several factors, including the XIST gene which we
found to be highly up-regulated (12 fold) in females. Furthermore, four genes identified here
(HDHD1, RPS4X,KDM6A, and ZFX) were found to have higher expression in females in vari-
ous human tissues [29], although in that study only KDM6A (alias UTX) was differentially
expressed in lung tissue. We also observed the sex-biased expression of genes never reported
to escape from X-inactivation in human tissue and also of genes mapping on autosomes, sug-
gesting the existence of other mechanisms of sex-dependent transcriptional control in lung tis-
sue. As we did not find any functional category enriched among male- or female-specific
genes, we cannot hypothesize about the mechanisms involved. Of note, in our analysis we did
not consider the possible confounding effects of hormonal status on gene expression. Due to
the small number (n = 8 women younger than 50 years of age) of non- or pre-menopausal
females in our series, we doubt that menopausal status had any relevant impact on our results.
Indeed, any subgroup analysis based on age in females would be severely biased by a very
small sample size in one subgroup. Finally, we also noticed that >70% (i.e., 18/25) of the sex-
related genes that passed validation showed a differential expression in males and females
Table 3. Genes whose expression in tissue associated with patients’ age at surgery in the discovery series and in all three validation series.
Symbol Gene name Gene Entrez ID Chr. Estimate 1 FDR 1
AGR2 Anterior gradient 2 10551 7 -0.01213 2.95E-02
CRYAB Crystallin, alpha B 1410 11 0.013824 1.60E-03
CXCL17 Chemokine (C-X-C motif) ligand 17 284340 19 -0.00911 4.85E-02
CXCL9 Chemokine (C-X-C motif) ligand 9 4283 4 0.028698 3.35E-02
DIRAS3 DIRAS family, GTP-binding RAS-like 3 9077 1 0.008936 3.00E-03
FANCE Fanconi anemia, complementation group E 2178 6 -0.01075 1.10E-03
FMO3 Flavin containing monooxygenase 3 2328 1 0.0131 1.44E-02
GSTA4 Glutathione S-transferase A4 2941 6 -0.01173 4.80E-03
ITGB5 Integrin, beta 5 3693 3 0.007076 4.19E-02
ITGBL1 Integrin, beta-like 1 (with EGF-like repeat domains) 9358 13 0.018297 1.21E-05
LCN2 Lipocalin 2 (oncogene 24p3) 3934 9 -0.02576 3.78E-02
MGP Matrix Gla protein 4256 12 0.00841 4.97E-02
PGM5 Phosphoglucomutase 5 5239 9 0.009683 4.80E-02
PLCD3 Phospholipase C, delta 3 113026 17 0.005974 1.42E-02
PTCHD4 Patched domain containing 4 442213 6 0.003035 4.85E-02
RCAN2 Regulator of calcineurin 2 10231 6 0.015413 1.56E-04
RERGL RERG/RAS-like 79785 12 0.022899 6.70E-03
SCARF2 Scavenger receptor class F, member 2 91179 22 0.009692 1.96E-02
TC2N Tandem C2 domains, nuclear 123036 14 -0.00923 3.78E-02
WISP2 WNT1 inducible signaling pathway protein 2 8839 20 0.026326 9.02E-05
ZMAT3 Zinc finger, matrin type 3 64393 3 0.016636 1.84E-04
ZNF518B Zinc finger protein 518B 85460 4 -0.00626 4.07E-02
1 Values are those observed in the discovery series.
doi:10.1371/journal.pone.0167460.t003
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already in fetal lung, indicating that sexual differences in lung transcriptome are, at least in
part, established at the developmental level.
Regarding age-dependent modulation of transcription, our study builds on preliminary evi-
dence [9] of age-related changes in gene expression in non-tumor lung tissue and defines a
lung-specific aging signature of 22 genes. Only the HEPH gene of our 22 genes was also present
in the preliminary age-related signature of 40 genes reported in [9]. Five genes in our signature
have previously been associated with aging in skin and/or adipose tissue [6]. In particular, two
of them (DIRAS3, and WISP2) were found to be up-regulated in aged skin; two genes (CXCL9
and RCAN2) were up-regulated with age in adipose tissue; and FMO3 was reported up-regu-
lated in both aged skin and adipose tissue. Their involvement in aging lung, reported here, sug-
gests that these genes may have broad roles in the aging process.
None of the 22 age-related genes identified in this study belongs to the transcriptional sig-
nature of aging defined in a meta-analysis of multiple tissues from humans, rat and mice [8].
That study identified age-dependent modifications in the expression of genes involved in sev-
eral biological processes, including pro-inflammatory response genes, and extracellular matrix
function. We, too, found age-related changes in the expression of genes involved in pro-
inflammatory responses and genes encoding extracellular matrix components, in our discov-
ery series. Although there were no common genes between our study and the meta-analysis
described in [8], pathways related to the pro-inflammatory responses and to the extracellular
matrix are important in lung function and disease. The known age-related increase in pulmo-
nary inflammation, as observed for example in lungs of patients with chronic obstructive pul-
monary disease (COPD) [30], may reflect the lungs’ exposure, over the course of a lifetime, to
environmental pollutants and microorganisms. Also, age-related changes in extracellular
matrix alter the mechanisms of lung repair and lead to abnormal wound healing and fibrosis
(reviewed in [31]). Such alterations are often observed, respectively, in COPD and in idio-
pathic pulmonary fibrosis, both associated with aging [32,33]. Therefore, the age-related genes
identified in our study are worthy of further investigation to understand their possible involve-
ment in these pulmonary diseases.
Interestingly, seven genes belonging to the sex-associated profile from non-involved lung
tissue were also validated in four lung cancer series. This finding suggests that some sex-related
transcriptome changes are maintained in neoplastic tissue which, therefore, is controlled to a
certain degree by the same sex-linked factors active in normal lung tissue. In the same four
lung cancer series, however, we did not validate any genes from the age-related expression pro-
file and only one gene showed a significant association with age in at least one of the four data-
sets. This result suggests that gene expression in lung tumor tissue is not affected by factors
associated with aging in non-tumor tissue.
One limitation of our study is that we do not have more details about patients’ smoking
habits (e.g. years of smoking, packs per year) in the discovery series; thus we could not take
into account this aspect in our analyses. Also, the study was carried out in whole lung tissue;
therefore, the cell-specificity of expression of the validated genes should be further investigated
by immunohistochemical studies.
Two other limitations of our study, which might explain the low number of validated sex-
and age-related genes, are the use of different platforms for gene expression analysis in the dis-
covery versus validation series, and the high degree of heterogeneity, in terms of patients’ ages,
sex distribution, smoking habits, and types of lung pathology, of the validation series com-
pared with the discovery series. Indeed, the number of validated genes is quite low (around
10% of those found in the discovery series for both sex and age), but the validation was carried
out on three independent datasets. Because this approach is stringent, it results in a lower
number of validated genes than had we used only a single validation dataset, as seen in the
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majority of published reports. The relatively few genes validated in our study represent the
core of genes that are always significantly associated with sex or age in all of the datasets ana-
lyzed; we believe that these are true positives. If we are less stringent and consider the genes
found significant in at least one dataset, the numbers of validated genes increase from 25 to
102 for sex and from 22 to 165 for age.
It is interesting to notice that more genes were validated for sex and age in the Laval series,
which is clinically most similar to the Italian discovery series, than in the other two validation
series. This finding suggests that the transcriptional profiles identified in the Italian discovery
series contain a high percentage of real positive associations. This is also supported by permu-
tation analysis results indicating a very low possibility that the obtained numbers of sex- or
age-related genes were due to chance.
The mechanisms underlying the observed differential sex or age expression of genes in lung
may be due to differences in DNA methylation. Indeed, sex differences in DNA methylation,
leading to differential gene expression at various loci, have been reported [34]. Moreover, age-
related changes in DNA methylation have also been observed [35].
Overall, we found that, in non-tumor lung tissue, several genes undergo a modulation of
their expression, which depends on either sex or age of the examined individual. Our findings
provide a reliable starting point for a deeper investigation at the molecular level of the role of
sex and age in the pathophysiology of lung tissue.
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